| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |